In cancer patients, terminally exhausted cells (TEX) can be distinguished from conventional effector CD8+ T cells by increased expression of inhibitory receptors including PD-1, TIGIT, TIM-3 and LAG-3. This evidence concerns the gene CD8A and cancer.